About Chuba Oyolu
Form D filings for Curve Biosciences in 2024 list Chuba Oyolu as executive officer.
Chuba Oyolu first appears on SEC filings in 2024.
Experience
This experience comes from SEC filings. The years are when the filings name Chuba Oyolu in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Chuba Oyolu works with at each company, as listed on that company's latest Form D.
Curve Biosciences, Inc. · Form D, May 13, 2024
NH
Nathan Hunkapiller
Executive officer
SW
Shan Xiang Wang
Executive officer and director
TK
Themasap Khan
Director
RP
Ritish Patnaik
Chief Executive Officer and director